Aurinia Pharmaceuticals Inc (AUPH) Event Aug. 04, 2022, 10:07 UTC 14 1 comments (30% Negative) Aurinia Pharmaceuticals Inc. (AUPH) Reports Q3 2022 Financial Results Comment Full text
AstraZeneca (AZN) Event Aug. 04, 2022, 10:02 UTC 10 1 comments (90% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K) Comment Full text
Moderna Inc (MRNA) Event Aug. 04, 2022, 09:59 UTC 93 0 comments Moderna - Annual R&D Day 2022 Comment Full text
Rain Therapeutics Inc. (RAIN) Event Aug. 04, 2022, 05:01 UTC 92 0 comments Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma Comment Full text
Cytokinetics Inc (CYTK) Event Aug. 04, 2022, 04:32 UTC 90 0 comments Cytokinetics and The ALS Association Announce Release of Updated PRO-ACT Database Including Data From Cytokinetics’ Completed ALS Clinical Trials Comment Full text
Passage Bio Inc. (PASG) Event Aug. 04, 2022, 04:04 UTC 91 0 comments Passage Bio, Inc. - Corporate Presentation - August 2022 Comment Full text
Royalty Pharma (RPRX) Event Aug. 04, 2022, 00:00 UTC 15 1 comments (70% Positive) Royalty Pharma plc (RPRX) Reports 43% Profit Growth for 2022-06-30 Comment Full text
Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Event Aug. 04, 2022, 00:00 UTC 28 1 comments (61% Neutral) AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Reports Net Loss for 2022-06-30 Comment Full text
Aurinia Pharmaceuticals Inc (AUPH) Event Aug. 04, 2022, 00:00 UTC 24 1 comments (28% Negative) Aurinia Pharmaceuticals Inc. (AUPH) Reports 33% Loss Increase for 2022-06-30 Comment Full text
Madrigal Pharmaceuticals Inc (MDGL) Event Aug. 04, 2022, 00:00 UTC 22 1 comments (47% Neutral) MADRIGAL PHARMACEUTICALS, INC. (MDGL) Reports 108% Loss Increase for 2022-06-30 Comment Full text